| Financial Year |
March 31 2023 |
| Monetary Funds |
487,441,125.07 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
18,835,977.82 |
| Accounts Receivable |
888,598,702.96 |
| Advances to Suppliers |
48,571,827.30 |
| Other Receivables |
12,286,527.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
417,810,433.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
90,470,600.27 |
| Total Current Assets |
1,992,016,808.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
70,628,919.49 |
| Investment Properties |
28,915,967.19 |
| Fixed Assetes |
2,001,348,590.45 |
| Under-construction Projects |
2,239,688,612.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
180,973,184.10 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,763,341.27 |
| Deferred Income Tax Assets |
108,632,029.99 |
| Other Non-Current Assets |
54,918,645.64 |
| Sub-Total of Non-Current Assets |
4,715,974,069.28 |
| Total Assets |
6,707,990,877.70 |
| Short-Term Loans |
806,602,712.38 |
| Trading Financial liabilities |
411,225.00 |
| Notes Payable |
233,199,494.10 |
| Accounts Payable |
326,213,883.58 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,546,947.02 |
| Taxes Payable |
7,428,499.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
14,711,090.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
251,817,154.70 |
| Other Current Liabilities |
428,427.28 |
| Sub-Total of Current Liabilities |
1,678,017,188.86 |
| Long-term Loans |
2,251,582,240.95 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
15,610,742.38 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
326,219.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,847,336,692.86 |
| Total Liabilities |
4,525,353,881.72 |
| Paid-In Capital(Or Share Stock) |
324,013,402.00 |
| Capital Surplus |
913,646,823.23 |
| Surplus Reserve |
77,505,763.98 |
| LESS:Treasury Stock |
13,188,611.11 |
| Undistributed Profits |
879,653,221.63 |
| Minority Stockholder's Interest |
1,923,000.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,180,713,995.96 |
| Owner's Equity（Stockholder's Equity） |
2,182,636,995.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,707,990,877.70 |
